| Geld/Brief | 56,92 € / 57,48 € |
| Spread | +0,98% |
| Schluss Vortag | 57,35 € |
| Gehandelte Stücke | 0 |
| Tagesvolumen Vortag | - |
| Tagestief 56,33 € Tageshoch 57,66 € | |
| 52W-Tief 40,67 € 52W-Hoch 102,70 € | |
| Jahrestief 40,67 € Jahreshoch 102,70 € | |
| Umsatz in Mio. | 1.534 $ |
| Operatives Ergebnis (EBIT) in Mio. | 456,98 $ |
| Jahresüberschuss in Mio. | 312,44 $ |
| Umsatz je Aktie | 22,16 $ |
| Gewinn je Aktie | 4,51 $ |
| Gewinnrendite | +28,72% |
| Umsatzrendite | +20,37% |
| Return on Investment | +15,78% |
| Marktkapitalisierung in Mio. | 6.192 $ |
| KGV (Kurs/Gewinn) | 19,84 |
| KBV (Kurs/Buchwert) | 5,69 |
| KUV (Kurs/Umsatz) | 4,04 |
| Eigenkapitalrendite | +28,72% |
| Eigenkapitalquote | +54,94% |
| Faktor-Zertifikate | 22 | |
| Knock-Outs | 10 |
| 31.12.2025 | Quartalsmitteilung |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| Düsseldorf | 56,86 € | +0,21% | 56,74 € | 30.12.25 | |
| Frankfurt | 56,52 € | +0,28% | 56,36 € | 30.12.25 | |
| Hamburg | 57,12 € | +0,85% | 56,64 € | 30.12.25 | |
| München | 56,68 € | 0 % | 56,68 € | 30.12.25 | |
| Stuttgart | 56,72 € | +0,11% | 56,66 € | 30.12.25 | |
| L&S RT | 57,20 € | -0,26% | 57,35 € | 30.12.25 | |
| Berlin | 56,66 € | +0,35% | 56,46 € | 30.12.25 | |
| NYSE | 66,60 $ | +0,05% | 66,57 $ | 31.12.25 | |
| Nasdaq | 66,55 $ | -0,91% | 67,16 $ | 31.12.25 | |
| AMEX | 66,615 $ | -0,81% | 67,16 $ | 31.12.25 | |
| Tradegate | 56,92 € | -0,52% | 57,22 € | 30.12.25 | |
| Quotrix | 57,12 € | +0,39% | 56,90 € | 30.12.25 | |
| Gettex | 57,34 € | +0,53% | 57,04 € | 30.12.25 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 30.12.25 | 57,20 | - |
| 29.12.25 | 57,35 | - |
| 28.12.25 | 56,63 | - |
| 27.12.25 | 56,63 | - |
| 23.12.25 | 57,78 | - |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 57,78 € | -1,00% |
| 1 Monat | 50,91 € | +12,36% |
| 6 Monate | 68,00 € | -15,88% |
| 1 Jahr | 87,59 € | -34,70% |
| 5 Jahre | 11,25 € | +408,44% |
| Marktkapitalisierung | 3,94 Mrd. € |
| Aktienanzahl | 69,53 Mio. |
| Währung | EUR |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Pharmazeutika |
| Aktientyp | Stammaktie |
| +12,55% | BlackRock Inc |
| +10,21% | HHG PLC |
| +10,06% | Vanguard Group Inc |
| +9,89% | Farallon Capital Management, L.L.C. |
| +7,38% | FMR Inc |
| +3,76% | State Street Corp |
| +2,61% | Geode Capital Management, LLC |
| +2,53% | Wellington Management Company LLP |
| +2,48% | Amvescap Plc. |
| +2,20% | Westfield Capital Management Company, L.P. |
| +2,10% | T. Rowe Price Investment Management,Inc. |
| +2,06% | Reinhart Mahoney Capital Management Inc |
| +2,03% | Dimensional Fund Advisors, Inc. |
| +1,81% | Swedbank AB |
| +1,65% | Macquarie Group Ltd |
| +1,52% | T. Rowe Price Associates, Inc. |
| +1,49% | Silvercrest Asset Management Group LLC |
| +1,32% | JPMorgan Chase & Co |
| +1,27% | Northern Trust Corp |
| +1,23% | Charles Schwab Investment Management Inc |
| +19,85% | Weitere |
| 0,00% | Streubesitz |